Venus Concept announced that it has Therapeutic Goods Administration TGA clearance in Australia to market the Venus Versa Pro system. The Venus Versa Pro combines the applicator of the Venus Viva MD with the Venus Versa system which are both approved in Australia and registered in Australian Register of Therapeutic Goods ARTG . “We look forward to bringing our Venus Versa Pro system to Australia, a major market to which we continue to commit investment with a growing direct office presence,” said Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept. “Venus Versa Pro continues to receive positive feedback from customers regarding its multi-modal system capabilities and we look to bring the device to more customers globally once approved with the relevant local authorities.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERO:
- Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
- Venus Concept’s Operations Under Threat: Geopolitical Tensions in Israel Pose Risks to Business Continuity
- Venus Concept reports Q4 EPS ($2.01), consensus ($1.18)
- VERO Upcoming Earnings Report: What to Expect?
- Venus Concept granted continued listing from Nasdaq hearings panel